Deep TMS to help thinking in older adults with mild cognitive decline
Official title: Feasibility and Tolerability of Deep Repetitive Transcranial Magnetic Stimulation for Mild Neurocognitive Disorder in Older Adults: A Pilot Study (DeepMIND)
Run by St. Joseph's Healthcare Hamilton · NCT07038798 · Data updated 2026-11-12
This pilot will try three types of deep transcranial magnetic stimulation (H1, H4, H7 coils) to see how tolerable they are and whether they affect thinking, mood, sleep, and brain activity in adults aged 60–90 with mild neurocognitive disorder.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 60 Years to 90 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | St. Joseph's Healthcare Hamilton Academic / other |
| Locations | 1 site (Hamilton, Ontario) |
| Status | Recruiting |
| Started | August 26, 2025 |
| Main results expected | January 2027 |
| Study ends | January 2027 |
| Registry record updated | October 6, 2025 |
| Trial ID | NCT07038798 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 60–90 with self-reported recent cognitive decline, objective mild impairment on testing, preserved independence in daily activities, and stable psychotropic medications are the intended participants.
✕Probably not a fit
People with severe depression, bipolar or psychotic disorders, significant neurological illness explaining their cognitive problems, impaired basic or instrumental activities of daily living, recent substance use disorders, or standard rTMS contraindications are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This open-label, parallel pilot assigns participants aged 60–90 to one of three dTMS H-coils (H1, H4, H7) and delivers a six-week course of 20 stimulation sessions. Feasibility and tolerability are measured with side-effect checklists and mental-health questionnaires, while cognition is measured with neuropsychological tests and CNS Vital Signs and brain activity is recorded with EEG at baseline, midpoint, end point, and follow-up. Self-report mood and sleep questionnaires are collected at the same timepoints to capture noncognitive effects. The trial will compare absolute and differential tolerability across coils to provide preliminary data for a future randomized sham-controlled trial.
Why it matters
Potential benefit: If successful, one of the coils could offer a tolerable, noninvasive option to improve or stabilize cognition, mood, or sleep in older adults with mild neurocognitive disorder.
How similar studies have gone: dTMS is FDA-approved for several psychiatric conditions and small studies have suggested possible cognitive benefits in Alzheimer's and other neurodegenerative disorders, but its use in mild NCD remains preliminary and not yet established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 60 - 90 years old * Able to provide informed consent to participate in the study * Subjective concern of mild decline in cognitive function over the past year * Mild impairment in cognitive performance * Preserved independence in everyday activities * Independently mobile (e.g., participants must be able to get in and out of a chair on their own) * Participants will be required to be on stable dosages of other psychotropic medications for at least 4 weeks prior to screening Exclusion Criteria: * Currently receiving treatment or subjective need for treatment for bipolar I or II disorder; psychotic disorder * Active suicidal behavior * Severe depression and/or anxiety * Other neurological or psychiatric disorders accounting for the cognitive deficits * Impairment in basic and/or instrumental activities of daily living * Substance use disorder (other than tobacco use disorder) in the past 3 months before entering the study * Traditional contraindications to rTMS: Intracranial or metal implants in the head or nearby regions, excluding the mouth, that cannot be safely removed; History of epilepsy or seizures; Active unstable medical condition (recent laboratory and neuroimaging alterations, delirium); Pacemaker and/or implantable cardioverter-defibrillators; current use of bupropion, treatment with equivalent benzodiazepine dose to lorazepam \>2 mg/day * People with severe literacy, visual, or hearing issues that affect the ability to engage in the interviews * People with recurring migraines or headaches (weekly or more) * Frequent dizziness/vertigo * Individuals residing beyond the borders of the Greater Hamilton Area and its neighbouring vicinities
Where it's running
-
Peter Boris Centre for Addictions Research, St. Joseph's Healthcare Hamilton
Hamilton, Ontario, Canada Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Non-invasive brain stimulation plus computer-based memory training for mild cognitive impairment
This trial will test whether a short course of non-invasive brain stimulation combined with one of two computer-based brain-training programs helps people aged 60–85 with mild cognitive impairment improve memory, thinking, mood, and daily function.
-
Comparing endovascular therapy and best medical treatment for mild acute stroke with large vessel occlusion
This study is testing whether a special treatment for stroke called endovascular therapy can help people with mild strokes caused by a blocked blood vessel feel better compared to just using standard medical care.
-
Do medicines that lengthen the heart's QT interval cause serious heart problems in hospitalized adults?
This project will test whether commonly used hospital medicines that can prolong the heart's QT interval lead to serious cardiac events in adults admitted to Ontario hospitals.
-
Teaching undergraduates how the body controls weight and healthy eating to improve body image and self-esteem
This project will test whether teaching undergraduate women who are dieting about natural weight regulation and healthy eating changes their beliefs about weight and improves body image, self-esteem, and dieting intentions.
-
Pilot of two online programs to support people with substance use after release from federal prison
This project will test two online programs—Breaking Free Online and CBT4CBT—for people recently released from federal custody to help manage substance use and reduce the chance of returning to prison.
-
Mindfulness and body-awareness program for postpartum anxiety
This study will test a 4-week mindfulness-based program to see if it helps mothers in the first year after delivery with anxiety improve emotion regulation and awareness of bodily signals.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.